0001179110-20-002264.txt : 20200225
0001179110-20-002264.hdr.sgml : 20200225
20200225171428
ACCESSION NUMBER: 0001179110-20-002264
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200221
FILED AS OF DATE: 20200225
DATE AS OF CHANGE: 20200225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Funck Robert E
CENTRAL INDEX KEY: 0001565892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 20652093
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD, AP6C-1N
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
edgar.xml
FORM 4 -
X0306
4
2020-02-21
0
0000001800
ABBOTT LABORATORIES
ABT
0001565892
Funck Robert E
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6400
0
1
0
0
Senior Vice President
Common shares without par value
2020-02-21
4
A
0
25265
0
A
177438
D
Common shares without par value
17570
I
Profit Sharing Trust
Common shares without par value
500
I
By Daughter
Common shares without par value
500
I
By Daughter
Option (right to buy)
87.72
2020-02-21
4
A
0
154013
0
A
2021-02-21
2030-02-20
Common shares
154013
154013
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2020.
The reporting person disclaims beneficial ownership of all securities held by his daughter.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 51,337 on February 21, 2021, 51,338 on February 21, 2022, and 51,338 on February 21, 2023.
Jessica H. Paik, Attorney-in-Fact for Robert E. Funck Jr.
2020-02-25